<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04209413</url>
  </required_header>
  <id_info>
    <org_study_id>RNI 2019 RICHARD</org_study_id>
    <secondary_id>2019-A01109-48</secondary_id>
    <nct_id>NCT04209413</nct_id>
  </id_info>
  <brief_title>Control of the Opening of mPTP by Ex Vivo Measurements on Permeabilized Muscle Fibers (COMMEF)</brief_title>
  <acronym>COMMEF</acronym>
  <official_title>Control of the Opening of mPTP by Ex Vivo Measurements on Permeabilized Muscle Fibers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CRNH Auvergne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      mPTP (Mitochondrial Permeability Transition Pore) is a channel formed by a protein complex&#xD;
      integrated into the inner membrane of mitochondria. Its opening is related to the elevation&#xD;
      of the intra-mitochondrial calcium concentration and will result in: a mitochondrial&#xD;
      decoupling, a rupture of the metabolic gradient and the release of pro-apoptotic factors.&#xD;
&#xD;
      The objective of this study is the development of a new ex vivo technique for characterizing&#xD;
      mPTP by a dual measurement combining oxygraphy and fluorimetry on permeabilized skeletal&#xD;
      muscle fibers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The development of new expertise in the study of mPTP is part of an approach to optimize the&#xD;
      processing of muscle samples. The aim of this work is to evaluate the feasibility and&#xD;
      reproducibility of a method of analysis on muscle fibers only permeabilized, while coupling&#xD;
      two complementary techniques, oxygraphy and fluorimetry. Its principle is based on the&#xD;
      knowledge that the opening of the mPTP leads to an inhibition of respiration at the level of&#xD;
      the complex I of the respiratory chain. This inhibition is the consequence of the escape from&#xD;
      mitochondria of the reduced form of nicotinamide adenine dinucleotide (NADH, i.e. substrate&#xD;
      of complex I) concomitant with the opening of mPTP. Thus, the oxygraphy must allow the&#xD;
      observation of the inhibition of respiration synonymous with the non-availability of the&#xD;
      substrate of the complex I and thus indirectly reflect the opening of the mPTP. For its part,&#xD;
      the fluorimetry must allow, in the presence of a fluorescent calcium indicator (i.e. Calcium&#xD;
      Green), the observation of the release of calcium synonymous with the opening of the mPTP.&#xD;
&#xD;
      Once validated, this technique should make it possible to evaluate in situ the sensitivity of&#xD;
      mPTP to calcium. In a context of application within clinical protocols, the evaluation of the&#xD;
      mPTP calcium sensitivity should contribute to a better understanding of the physiological and&#xD;
      physio-pathological mechanisms of adaptation of muscle tissue.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 20, 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of the mPTP calcium sensitivity mPTP</measure>
    <time_frame>day 0</time_frame>
    <description>The goal is to study the feasibility of a new method for the analysis of the calcium sensitivity of mPTP on non-phantomized permeabilized muscle fibers by coupled use of oxygen and fluorimetry techniques. Calcium quantity and time required to open mPTPs in permeabilized muscle fibers will be measured, in the presence or absence of ciclosporin A, observable by total inhibition of mitochondrial respiration (synonymous with release of NADH).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification of mPTP opening discrimination factors</measure>
    <time_frame>Day 0</time_frame>
    <description>Evaluate the possibility of population discrimination by this new method of analysis (i.e. variability by age and duration of functional impotence before intervention of the amount of calcium required to open the mPTP).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Anterior Cruciate Ligament Injuries</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Patients referred for a knee ligamentoplasty</intervention_name>
    <description>knee ligamentoplasty</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for a knee ligamentoplasty&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged over 18 ;&#xD;
&#xD;
          -  Patients referred for a knee ligamentoplasty (DIDT technique) ;&#xD;
&#xD;
          -  Patients who signed the non-opposition form after being informed ;&#xD;
&#xD;
          -  Patients benefiting from or affiliated to a social security.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Patients under guardianship, curatorship or deprived of liberty.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruddy Richard</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lise LACLAUTRE</last_name>
    <phone>+334.73.754.963</phone>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruddy Richard</last_name>
      <email>rrichard@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Ruddy Richard</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane Descamps</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane Boisgard</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 20, 2019</study_first_submitted>
  <study_first_submitted_qc>December 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2019</study_first_posted>
  <last_update_submitted>January 21, 2020</last_update_submitted>
  <last_update_submitted_qc>January 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anterior Cruciate Ligament operation</keyword>
  <keyword>Skeletal muscle</keyword>
  <keyword>Mitochondria</keyword>
  <keyword>Calcium</keyword>
  <keyword>Mitochondrial permeability transition pore opening (mPTP opening)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anterior Cruciate Ligament Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

